VERIFIEDET Finance·8 Sept 2026neutral

Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug

AI Summary

·Biocon has entered into a ten-year agreement in Brazil for Pertuzumab.
·The deal was facilitated through collaborations with Bahiafarma and Bionovis.
·The agreement grants exclusive rights to supply Brazil's public healthcare sector with phased production localization planned.